Association of a CB1 receptor antagonist with a product that enables the dopaminergic neurotransmission in the Brain, Pharmaceutical compositions containing them and their use in the treatment of Parkinson's disease

摘要

This refers to the Association of one or more Derivatives of azetidine CB1 antagonists with one or more products Activate the dopaminergic neurotransmission in the Brain, and also relates to the pharmaceutical compositions containing them and their use in the treatment of L In Parkinson's disease.